Covance Clinical Development (Phase II-IV) Service by Covance Laboratories Inc.

The stakes are high as your drug enters clinical development in Phase II-III. With your drug’s future on the line, you need to navigate a global maze of patient populations, practice patterns and regulatory requirements, often also languages and time zones, before the goal of regulatory approval is in sight. It’s challenging and requires a broad range of expert resources.

That’s why Clinical Development Phase II-III is there to help you manage the complex clinical development experience simply, efficiently, comprehensively and successfully.


Service Features:

• Comprehensive planning through Covance’s P3 (predictive, proactive, preventative) Operating Platform - builds quality into your trials before they begin, helping to prevent errors, proactively minimize delays and mitigate risks, and optimize performance.
• Access to Covance’s end-to-end suite of services - offers all the resources you need for global clinical trials in Phase II-III
• High quality data, on time and without surprises - based on our ability to coordinate and align numerous global data streams
• Clinical trial support in more than 55 countries - an unparalleled reach through our worldwide network of scientific and operational professionals, who are experts in local regulatory, health, and research issues
• A simplified approach to contracting and vendor management - that frees you from the burden of coordinating subcontractors, making internal decisions, and supervising operational hand-offs, letting you spend more time on core tasks.
• You access these and other benefits through your project manager, a seasoned professional with relevant scientific and therapeutic expertise who serves as your central contact throughout the entire process. And whose sole mission is your success.